Please try another search
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Nicholas John McCooke | 70 | 2014 | Independent Non-Executive Director |
Ian James Nicholson | 63 | 2004 | Independent Non-Executive Chairman |
Peter John Harrison | 65 | - | CEO & Director |
Bruce Edward Heath Hiscock | 65 | 2020 | CFO & Director |
Joanne Patra Pisani | 58 | 2023 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review